|
Partners Group Private Equity Ltd on Monday said its net asset value fell in December, as it was hit by continued US dollar weakness against the euro. The Guernsey-based private equity investor managed by Partners Group Holding AG said NAV fell 2.8% to €13.00 per share at the end of December. The NAV total return for the full calendar year was down 8.7%, primarily impacted by 5.7% of currency headwinds. Portfolio revaluations impacted December NAV by 2.1%, while unfavourable currency movements had a negative 0.6% effect. PGPE said NAV was affected by ‘continued US dollar weakness against the euro’ as well as revaluations related to two direct investments in December. It noted belting solutions firm Ammega Group BV was hit by continued industry-wide softer trading while Pharmathen SA ‘experienced a disruption in its long acting injectables manufacturing operations’. Pharmathen is a contract development and manufacturing organisation which specialises in advanced drug delivery. PGPE said it received €57.7 million in December, taking full year proceeds to more than €200 million. The firm noted that a ‘significant portion’ of December’s proceeds came from International Schools Partnership, after the sale of a 20% stake to CVC Strategic Opportunities. PGPE said a total of €57.6 million was distributed to shareholders in 2025, mostly through €51.8 million in dividends. The company added that it has extended its share buyback programme through to the end of April, to enable utilisation of the remaining allocated amount. Shares in Partners Group Private Equity were flat at €9.74 at midday on Monday in London. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
